Class I

Drug Recall: ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com

Boulla LLC · November 4, 2024

Reason for Recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

Unknown

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0085-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.